Question explored with the scientific record
Conversation so far
- 1 Amoxicillin + clavulanic acid
- 2 When is Augmentin better than plain amoxicillin or a shorter course?
Answered on this page ↓
When is Augmentin better than plain amoxicillin or a shorter course?
Augmentin beats plain amoxicillin only when a beta-lactamase-producing bacterium is confirmed or highly probable. Shorter courses work for most uncomplicated infections. Longer courses matter only for certain ear infections in young children.
The clavulanate in Augmentin blocks the enzyme (beta-lactamase) that some bacteria use to destroy amoxicillin. Without that enzyme, plain amoxicillin works as well and carries less risk. The trade-off is real: compared to plain amoxicillin, Augmentin causes about 4 times more liver injury reports, and those injuries are more often serious [7].
When Augmentin genuinely beats plain amoxicillin. Bite wounds. Animal and human bite wounds carry Pasteurella and anaerobes that produce beta-lactamase, and Augmentin is the standard empiric choice [4]. Diabetic foot infections. The mix of aerobes and anaerobes (Staphylococcus, Bacteroides) in diabetic ulcers makes Augmentin a reasonable option [11]. Breast abscesses. Anaerobic bacteria isolated from breast abscesses were 100% susceptible to Augmentin [10]. Skin infections where lab culture shows beta-lactamase producers [3]. Tuberculosis. Some drug-resistant M. tuberculosis isolates are susceptible to amoxicillin-clavulanate, with MICs as low as 1-2 mg/L [5].
When a shorter course works just as well. For community-acquired pneumonia in outpatients, a 3-day course of azithromycin matched a 7-day course of Augmentin clinically (93% vs 93%) with fewer side effects [8]. For uncomplicated acute diverticulitis, a short IV course followed by oral antibiotics saved hospital costs without worse outcomes [2]. For acute sinusitis in adults, 5-7 days of any antibiotic provided only modest benefit over watchful waiting, with about 27% of patients reporting adverse effects [9].
When the longer course actually matters. In children under 3 with acute otitis media, a 10-day course of Augmentin cut treatment failure to 16% compared to 34% for a 5-day course—a difference of 17 percentage points [1]. Children with both ears infected or exposure to other children benefited most [1]. For protracted bacterial bronchitis in children, 14 days of Augmentin is standard [6].
| Condition | Augmentin better? | Duration | Key evidence |
|---|---|---|---|
| Bite wounds | Yes, first-line [4] | 3-5 days prophylaxis, 7-14 if infected | Pasteurella and anaerobes |
| Otitis media (child <3) | Yes, over plain amoxicillin if beta-lactamase suspected | 10 days beats 5 [1] | Failure 16% vs 34% |
| Pneumonia (adult outpatient) | No; azithromycin matches it [8] | 3-5 days | Clinical success ~93% both |
| Sinusitis (adult) | Modest benefit over placebo; alternatives exist [9] | 5-7 days | NNT 7-18 |
| Diabetic foot | Yes, reasonable empiric choice [11] | 7-14 days | Mixed aerobes/anaerobes |
| Bronchitis (protracted, child) | Yes, first-line [6] | 14 days | Non-typeable H. influenzae common |
My call: Use Augmentin only when the infection site (bite, diabetic foot, breast abscess) or lab result confirms beta-lactamase-producing bacteria. For routine ear, sinus, or chest infections in otherwise healthy people, plain amoxicillin or a short macrolide course is safer and often as effective. Confidence: high for the bite-wound and pneumonia comparisons from randomized evidence; moderate for diabetic foot and sinusitis.
Sources used 11
-
Acute Otitis Media — The Long and the Short of It
This study reviews the management of acute otitis media in children, emphasizing the effectiveness of a 10-day course of amoxicillin-clavulanate compared to a 5-day course, highlighting the implications for clinical practice and antibiotic resistance.
DOI: 10.1056/NEJMe1614712 -
Prospective randomized clinical trial assessing the efficacy of a short course of intravenously administered amoxicillin plus clavulanic acid followed by oral antibiotic in patients with uncomplicated acute diverticulitis
This study demonstrates that uncomplicated acute diverticulitis can be effectively managed with a short course of intravenous amoxicillin plus clavulanic acid followed by oral antibiotics, resulting in significant cost savings and comparable treatment outcomes to longer intraven…
DOI: 10.1007/s00384-010-0967-9 -
Further Experience with Augmentin in the Treatment of Skin Infections
A clinical evaluation of Augmentin (amoxicillin-clavulanic acid) in 32 patients with various skin infections, showing high clinical/microbiological cure rates, acceptable tolerability, and eradication of common pathogens, suggesting Augmentin is effective for mixed penicillinase…
DOI: 10.1177/00369330820270s108 -
Facial bite wounds: management update
A comprehensive narrative review updating the management of facial bite wounds (dog, cat, and human), covering infection risks, wound care, antibiotic prophylaxis, and facial-specific surgical considerations to optimize infection outcomes and cosmetic results.
DOI: 10.1016/j.ijom.2005.04.001 -
Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
This study investigates the susceptibility of drug-resistant Mycobacterium tuberculosis isolates in Korea to β-lactam antibiotics, specifically amoxicillin-clavulanate and meropenem-clavulanate, and identifies genetic mutations associated with resistance.
DOI: 10.4046/trd.2021.0175 -
Review shows paediatric protracted bacterial bronchitis needs an accurate diagnosis and strictly targeted extended antibiotics
This mini-review evaluates European data on paediatric protracted bacterial bronchitis (PBB), clarifies diagnostic criteria and antibiotic treatment (primarily two weeks of amoxicillin-clavulanic acid), discusses recurrence and bronchiectasis risk, and highlights the paucity of …
DOI: 10.1111/apa.14705 -
Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy
This study analyzes adverse drug reactions reported in Italy to compare the safety profiles of amoxicillin and amoxicillin/clavulanic acid, revealing that the latter is associated with a higher risk of serious adverse effects, particularly liver damage and Stevens-Johnson syndro…
DOI: 10.1093/jac/dkm111 -
Efficacy and Safety of Azithromycin 1 g Once Daily for 3 Days in the Treatment of Community-Acquired Pneumonia: an Open-Label Randomised Comparison with Amoxicillin-Clavulanate 875/125 mg Twice Daily for 7 Days
This study demonstrates that a 3-day course of oral azithromycin 1 g once daily is at least as effective as a standard 7-day course of oral amoxicillin-clavulanate 875/125 mg twice daily in treating outpatients with community-acquired pneumonia.
DOI: 10.1179/joc.2008.20.1.77 -
Acute Sinusitis in Adults
This NEJM Clinical Practice article reviews the diagnosis and management of acute sinusitis in adults, showing that antibiotics provide modest short‑term benefits over watchful waiting but carry notable adverse effects, and emphasizing shared decision‑making, guideline concordan…
DOI: 10.1056/NEJMcp1601749 -
Breast Abscesses Caused by Anaerobic Microorganisms: Clinical and Microbiological Characteristics
Antibiotic susceptibility profiling of 35 anaerobic bacteria from 24 breast abscesses ( Granada, Spain ) shows universal activity of imipenem, amoxicillin-clavulanic acid, and piperacillin-tazobactam across isolates, but substantial resistance to clindamycin, metronidazole, and …
DOI: 10.3390/antibiotics9060341 -
Bacteriological profile of diabetic foot
Diabetic foot infections in a 50-patient cohort revealed predominance of Staphylococcus aureus and Bacteroides spp with notable MRSA and ESBL/MBL producers, informing grade-dependent empiric antibiotic choices.
DOI: 10.18203/2349-2902.isj20210389